Taiwan
· Delayed Price · Currency is TWD Gongwin Biopharm Holdings Statistics
Total Valuation
TPEX:6617 has a market cap or net worth of TWD 14.75 billion. The enterprise value is 12.57 billion.
| Market Cap | 14.75B |
| Enterprise Value | 12.57B |
Important Dates
The next estimated earnings date is Thursday, April 17, 2025.
| Earnings Date | Apr 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6617 has 126.60 million shares outstanding. The number of shares has increased by 3.70% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 126.60M |
| Shares Change (YoY) | +3.70% |
| Shares Change (QoQ) | +10.44% |
| Owned by Insiders (%) | 24.20% |
| Owned by Institutions (%) | 0.04% |
| Float | 58.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.64 |
| P/TBV Ratio | 4.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -122.39 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -44.72 |
Financial Position
The company has a current ratio of 15.28, with a Debt / Equity ratio of 0.04.
| Current Ratio | 15.28 |
| Quick Ratio | 14.27 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.42 |
| Interest Coverage | -36.98 |
Financial Efficiency
Return on equity (ROE) is -4.40% and return on invested capital (ROIC) is -3.99%.
| Return on Equity (ROE) | -4.40% |
| Return on Assets (ROA) | -3.76% |
| Return on Invested Capital (ROIC) | -3.99% |
| Return on Capital Employed (ROCE) | -4.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.79% in the last 52 weeks. The beta is 0.63, so TPEX:6617's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -44.79% |
| 50-Day Moving Average | 112.38 |
| 200-Day Moving Average | 128.64 |
| Relative Strength Index (RSI) | 54.07 |
| Average Volume (20 Days) | 170,140 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6617 had revenue of TWD 31.76 million and -102.73 million in losses. Loss per share was -0.88.
| Revenue | 31.76M |
| Gross Profit | 17.97M |
| Operating Income | -152.01M |
| Pretax Income | -100.51M |
| Net Income | -102.73M |
| EBITDA | -144.10M |
| EBIT | -152.01M |
| Loss Per Share | -0.88 |
Balance Sheet
The company has 2.29 billion in cash and 117.03 million in debt, giving a net cash position of 2.17 billion or 17.17 per share.
| Cash & Cash Equivalents | 2.29B |
| Total Debt | 117.03M |
| Net Cash | 2.17B |
| Net Cash Per Share | 17.17 |
| Equity (Book Value) | 3.19B |
| Book Value Per Share | 25.09 |
| Working Capital | 2.33B |
Cash Flow
In the last 12 months, operating cash flow was -81.23 million and capital expenditures -199.92 million, giving a free cash flow of -281.15 million.
| Operating Cash Flow | -81.23M |
| Capital Expenditures | -199.92M |
| Free Cash Flow | -281.15M |
| FCF Per Share | -2.22 |
Margins
| Gross Margin | 56.58% |
| Operating Margin | -478.55% |
| Pretax Margin | -316.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6617 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.70% |
| Shareholder Yield | -3.70% |
| Earnings Yield | -0.70% |
| FCF Yield | -1.91% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6617 has an Altman Z-Score of 43.56.
| Altman Z-Score | 43.56 |
| Piotroski F-Score | n/a |